Immunoglobulin Market by Application (Hypogammaglobulinemia, Chronic Inflammatory Demyelinating Polyneuropathy, Immunodeficiency Disease, Myasthenia Gravis, Multifocal Motor Neuropathy, Idiopathic Thrombocytopenic Purpura, Inflammatory Myopathies, Specific Antibody Deficiency, Guillain-Barre Syndrome, and Others), Product Type (IGG, IGA, IGM, IGE, and IGD), and by Mode of Delivery (Intravenous and Subcutaneous): Global Opportunity Analysis and Industry Forecast, 2020-2030
Industry: Healthcare | Publish Date: 16-Oct-2024 | No of Pages: 679 | No. of Tables: 276 | No. of Figures: 246 | Format: PDF | Report Code : HC83
Speak to Our Analyst
Market Definition:
The Global Immunoglobulin Market size was valued at USD 11.23 billion in 2019 and is predicted to reach USD 20.23 billion by 2030 with a CAGR of 5.4% from 2020-2030.
Immunoglobulins are glycoproteins produced by plasma cells and other lymphocytes. Immunoglobulin protects the body from diseases by acting as an antibody to support the immune system against disease causing agents such as virus, bacteria and others. These are obtained from blood through fractionation process and then purified for different therapeutic and non-therapeutic applications. Immunoglobulins are classified into different classes and isotopes, biological features, and target structures among others. These antibodies are administered to the body trough intravenous and subcutaneous modes of drug delivery.
Market Dynamics and Trends
Key factors fueling the growth of the immunoglobulin market during the forecast period are increase in geriatric population along with rise in the number of hemophilic patients. Additionally, advanced technology coupled with enhanced purification processes have paved the way for improved immunoglobulin production. Other factors such as prevalence of chronic inflammatory diseases in conjunction with increasing awareness and reduced side effects are anticipated to drive market growth during the forecast period.
However, stringent government regulations along with risk of side effects are factors expected to hamper the immunoglobulin market growth. On the other hand, innovation, research and development are anticipated to create numerous opportunities in the immunoglobulin market during the forecast period.
Market Segmentations and Scope of the Study:
The immunoglobulin market is segmented on the basis of product, application, mode of delivery and region. On the basis of product, the market is segmented into IGG, IGA, IGM, IGE and IGD. On the basis of application, the market is segmented into Hypogammaglobulinemia, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Primary Immunodeficiency Disease, Myasthenia Gravis, Multifocal Motor Neuropathy, Idiopathic Thrombocytopenic Purpura (ITP), Inflammatory Myopathies, Specific Antibody Deficiency, Guillain Barre Syndrome, and Others. On the basis of mode of delivery, the market is segmented into intravenous and subcutaneous. Intravenous is sub segmented into 5% concentration, 10% concentration and others. Subcutaneous is sub segmented into 16.5% concentration, 20% concentration and others. Based on geography the market is segmented into North America, Europe, Asia Pacific and RoW.
Geographical Analysis
North America currently dominates the market and is anticipated to maintain its dominance throughout the forecast period. This is attributed to the factors such as presence of developed economies along with the rising prevalence of hemophilia. Also, other factors such as developed healthcare facilities, improved infrastructure and enhancement in technologies related to purification are anticipated to further propel the growth of the immunoglobulin market.
However, Asia Pacific is predicted to show rapid and consistent growth in market share within the forecast period owing to the increase in accessibility of healthcare facilities coupled with rising inflammatory diseases. Also, rising geriatric population in this region is expected to add revenue to the immunoglobulin market during the forecast period.
Competitive Landscape
Lucrative growth opportunities make the immunoglobulin market extremely competitive. Some of the major players in the market are CSL Ltd., Baxter international Inc., Octapharma AG, Grifols S.A, LFB SA, Kedrion Biopharma Inc., China Biologics Products, Inc., Biotest AG, Shire (Baxalta), and Bayer Healthcare among others. Strategic alliances, acquisitions and innovations along with R&D are key strategies used by market players to maintain market dominance.
For instance, in January 2019, Kedrion Biopharma announced that the U.S. Food and Drug Administration has accepted their Investigational New Drug (IND) application for a clinical study aimed at assessing efficacy and safety of a 10% intravenous immunoglobulin in the treatment of adult patients with primary immunodeficiency diseases (PID). This approval allows Kedrion to initiate clinical trial in the United States in coming months.
KEY BENEFITS
-
The immunoglobulin report provides the quantitative analysis of the current market and estimations through 2020-2030 that assists in identifying the prevailing market opportunities to capitalize on
-
The study comprises a deep dive analysis of the immunoglobulin market trend including the current and future trends for depicting the prevalent investment pockets in the market
-
The information related to key drivers, restraints and opportunities and their impact on the immunoglobulin market is provided in the report.
-
The market share of the players in the global immunoglobulin market along with their competitive analysis.
-
Value chain analysis in the market study provides a clear picture of the stakeholders’ roles.
KEY MARKET SEGMENTS:
By Product
-
IGG
-
IGA
-
IGM
-
IGE
-
IGD
By Application
-
Hypogammaglobulinemia
-
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
-
Immunodeficiency Disease
-
Myasthenia Gravis
-
Multifocal Motor Neuropathy
-
Idiopathic Thrombocytopenic Purpura (ITP)
-
Inflammatory Myopathies
-
Specific Antibody Deficiency
-
Guillain Barré Syndrome
-
Others
By Mode of Delivery
-
Intravenous
-
5% Concentration
-
10% Concentration
-
Others
-
-
Subcutaneous
-
16.5% Concentration
-
20% Concentration
-
Others
-
By Geography
-
North America
-
U.S
-
Canada
-
Mexico
-
-
Europe
-
Germany
-
France
-
UK
-
Italy
-
Austria
-
Russia
-
Rest of Europe
-
-
Asia-Pacific
-
Japan
-
China
-
India
-
Australia
-
Rest of Asia-Pacific
-
-
RoW
-
Brazil
-
Saudi Arabia
-
Argentina
-
Remaining Countries
-
KEY PLAYERS:
-
CSL Ltd.
-
Baxter international Inc.
-
Octapharma AG
-
Grifols S.A
-
LFB Group
-
Kedrion Biopharma Inc.
-
China Biologics Products, Inc.
-
Biotest AG
-
Shire PLC (Baxalta)
-
Bayer AG
REPORT SCOPE AND SEGMENTATION:
|
Parameters |
Details |
|
Analysis Period |
2019–2030 |
|
Base Year Considered |
2019 |
|
Forecast Period |
2020–2030 |
|
Market Size Estimation |
Billion (USD) |
|
Market Segmentation |
By Application (Hypogammaglobulinemia, Chronic Inflammatory Demyelinating Polyneuropathy, Immunodeficiency Disease, Myasthenia Gravis, Multifocal Motor Neuropathy, Idiopathic Thrombocytopenic Purpura, Inflammatory Myopathies, Specific Antibody Deficiency, Guillain-Barre Syndrome, and Others), Product Type (IGG, IGA, IGM, IGE, and IGD), and by Mode of Delivery (Intravenous and Subcutaneous) |
|
Geographical Segmentation |
North America (U.S., Canada, Mexico) Europe (UK, Germany, Italy, France, Austria, Russia, Rest of Europe), Asia-Pacific (China, Japan, India, Australia, Rest of APAC), Rest of the World (Brazil, Saudi Arabia, Argentina, Remaining Countries) |
|
Companies Profiled |
CSL Ltd., Baxter international Inc., Octapharma AG, Grifols S.A, LFB SA, Kedrion Biopharma Inc., China Biologics Products, Inc., Biotest AG, Shire (Baxalta), and Bayer Healthcare. |
At Next Move Strategy Consulting, we understand that insightful market research is the cornerstone of successful business decisions. That's why we employ a robust and multifaceted approach, combining various methodologies to deliver the most accurate and actionable data for our clients.
Research Landscape
We navigate the world of research with two primary approaches:
Qualitative Approach
Our qualitative research methodologies involve immersive techniques such as in-depth interviews, focus groups, and observational studies. By engaging directly with individuals and stakeholders, we uncover valuable insights that quantitative data alone may overlook.
Quantitative Research
In tandem with qualitative methodologies, NMSC leverages the power of Quantitative Research to provide a robust foundation of numerical insights. Through systematic data collection and analysis, we quantify patterns, preferences, and market trends, offering a comprehensive view of the business landscape.
Our quantitative research approach employs diverse tools, including surveys, experiments, and statistical modelling. These methodologies enable us to gather data from a large and representative sample, ensuring the statistical significance of our findings. By employing structured questionnaires and standardized data collection methods, we guarantee the reliability and validity of the information we present to our clients.
Quantitative research is particularly effective in measuring the prevalence of trends, assessing market size, and gauging the impact of various factors on consumer behavior. The numerical precision attained through this approach equips our clients with actionable insights, facilitating data-driven decision-making and strategy formulation.
Our Specialized Toolbox for Industry-Specific Market Research
We deploy a specialized arsenal of techniques tailored to meet your unique requirements. Here's a glimpse into our comprehensive toolbox:
Information Procurement
The stage entails acquiring market data or relevant information through various sources and methodologies.
Market Research Approach
We utilize both top-down and bottom-up approaches in market research analysis to achieve a comprehensive understanding of the market dynamics, leveraging the broad perspective of industry trends and macroeconomic factors alongside detailed insights from specific segments and individual companies.
Porters Five Forces Analysis
We conduct Porter's Five Forces analysis to evaluate the competitive landscape of an industry, providing us with insights into factors that affect profitability and strategic positioning.
SWOT Analysis
We conduct SWOT analysis to understand market trends, identify potential threats, capitalize on opportunities, and assess our strengths and weaknesses.
Forecasting
We utilize a forecasting model to predict future consumption by considering parameters like population, economics, regulations, market competition, drivers, constraints, technology, and pricing. We also employ statistical techniques such as multilinear regression, exponential smoothing, moving average, ARIMA, and Monte Carlo simulations for accurate predictions. In econometric forecasting, we analyzed short-term and long-term event impacts, attributing values based on regulatory frameworks, economic factors, and market events.
Frequently Asked Questions
Download Free Sample
Related Report
Related Blogs
A Performance Analysis on Key Players Operating in the Global Early Toxicity Testing Industry
Our analysis indicates substantial growth in the global earl...
From Breakouts to Breakthroughs: The Future of Acne Treatment
Introduction Acne, a universal skin concern, often seems like an unwelcome gu...
